e-learning
resources
Madrid 2019
Monday, 30.09.2019
Tuberculosis and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk Factors for tuberculosis in patients on anti-TNF treatment
Y. Kaptan (Izmir, Turkey), A. Sunel (Izmir, Turkey), M. Tas (Izmir, Turkey), F. Oksel (Izmir, Turkey), K. Aksu (Izmir, Turkey), A. Sayiner (Izmir, Turkey)
Source:
International Congress 2019 – Tuberculosis and comorbidities
Session:
Tuberculosis and comorbidities
Session type:
Thematic Poster
Number:
2974
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kaptan (Izmir, Turkey), A. Sunel (Izmir, Turkey), M. Tas (Izmir, Turkey), F. Oksel (Izmir, Turkey), K. Aksu (Izmir, Turkey), A. Sayiner (Izmir, Turkey). Risk Factors for tuberculosis in patients on anti-TNF treatment. 2974
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Risk factors for anti-tuberculosis treatment failure
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011
Risk factors for relapses of tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 345s
Year: 2003
Risk factors of hepatotoxicity during tuberculosis treatment and management
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008
Factors affecting the efficacy of treatment of MDR/XDR TB patients receiving bedaquiline
Source: International Congress 2019 – Tuberculosis: a public health approach
Year: 2019
Risk of tuberculosis in pediatric patients treated with biological agents
Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children
Year: 2020
Risk factors for tuberculosis in patients with chronic alcoholism
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Factors associated with completion of tuberculosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 428s
Year: 2005
Risk factors for extrapulmonar tuberculosis
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Anti-TNF-alpha therapy in patients with latent tuberculosis incidence
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Risk factors for tuberculosis relapse in Polish patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Risk of serious adverse reactions during the treatment of new tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016
Predictors of defaulting from treatment among patients with tuberculosis
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Risk factors associated with treatment interruption for 2 months among tuberculosis patients in Taipei
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007
Factors affecting tuberculosis treatment: the beliefs of patients
Source: Eur Respir J 2005; 26: Suppl. 49, 649s
Year: 2005
Risk factors for antibiotic re-administration in patients with pneumonia during hospitalization.
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results
Source: Eur Respir J 2001; 18: Suppl. 33, 467s
Year: 2001
Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Risk factors for discontinuation of roflumilast in COPD patients
Source: International Congress 2017 – COPD management
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept